Go to content
UR Home

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition

URN to cite this document:
urn:nbn:de:bvb:355-epub-530922
DOI to cite this document:
10.5283/epub.53092
Glehr, Gunther ; Riquelme, Paloma ; Yang Zhou, Jordi ; Cordero, Laura ; Schilling, Hannah-Lou ; Kapinsky, Michael ; Schlitt, Hans J. ; Geissler, Edward K. ; Burkhardt, Ralph ; Schmidt, Barbara ; Haferkamp, Sebastian ; Hutchinson, James A. ; Kronenberg, Katharina
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
(3MB)
Date of publication of this fulltext: 21 Oct 2022 10:37


Abstract

Immune checkpoint inhibitors have revolutionized treatment of advanced melanoma, but commonly cause serious immune-mediated complications. The clinical ambition of reserving more aggressive therapies for patients least likely to experience immune-related adverse events (irAE) has driven an extensive search for predictive biomarkers. Here, we externally validate the performance of 59 previously ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -4239

Contact persons